Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Akay

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
Hematology (Amsterdam, Netherlands)|July 13, 2018
Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-upGuray Saydam, Ibrahim Celalettin Haznedaroglu, Leylagul Kaynar, et al.
The Journal of International Medical Research|September 19, 2009
Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemiaM Sayitoglu, I C Haznedaroğlu, O Hatirnaz, et al.
Clinical Laboratory|September 9, 2020
Study for the Diagnostic Screening of Paroxysmal Nocturnal Hemoglobinuria in Older Patients with Unexplained Anemia and/or CytopeniaZehra N Ozdemir, Osman Ilhan, Gulsum Ozet, et al.
Leukemia & Lymphoma|September 13, 2024
A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patientsÖzgür Mehtap, Tayfur Toptas, Mehmet S Dal, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
Hematology (Amsterdam, Netherlands)|July 13, 2018
Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-upGuray Saydam, Ibrahim Celalettin Haznedaroglu, Leylagul Kaynar, et al.
The Journal of International Medical Research|September 19, 2009
Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemiaM Sayitoglu, I C Haznedaroğlu, O Hatirnaz, et al.
Clinical Laboratory|September 9, 2020
Study for the Diagnostic Screening of Paroxysmal Nocturnal Hemoglobinuria in Older Patients with Unexplained Anemia and/or CytopeniaZehra N Ozdemir, Osman Ilhan, Gulsum Ozet, et al.
Leukemia & Lymphoma|September 13, 2024
A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patientsÖzgür Mehtap, Tayfur Toptas, Mehmet S Dal, et al.
Pageof 15